{
    "id": "56609368",
    "text": "Rosmantuzumab (INN; development code OMP-131R10) is a humanized monoclonal antibody designed for the treatment of cancer. This drug was developed by OncoMed Pharmaceuticals.Statement On A Nonproprietary Name Adopted By The USAN Council - Rosmantuzumab, American Medical Association. == References == Category:Monoclonal antibodies ",
    "title": "Rosmantuzumab"
}